Clinical Trial Update: Hypofractionated Whole-Pelvis Radiotherapy (WPRT) vs Conventionally-Fractionated WPRT in Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial comparing hypofractionated whole-pelvis radiotherapy to conventionally-fractionated radiotherapy in prostate cancer is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Prostate Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING